CA-DIALPAD-INC.
17.6.2021 01:59:05 CEST | Business Wire | Press release
Dialpad Inc. , the industry leader in AI-powered communication and collaboration, today announced its platform integration with Microsoft Teams , a leading solution for team collaboration and engagement. Dialpad for Microsoft Teams is a cloud-native direct routing integration that seamlessly connects Dialpad’s enterprise-grade telephony features and award-winning Voice Intelligence (Vi™) capabilities into the Microsoft Teams native environment.
According to Microsoft’s Hybrid Work Trend Index , workers report that their productivity has either remained the same or increased over the past year. As work methods continue to evolve, Dialpad is at the forefront, creating better, smarter and more seamless communication experiences. With Dialpad direct routing at the heart of the integration, Microsoft Teams users have access to Dialpad’s global calling capabilities with PSTN connectivity in 49 countries in addition to sophisticated inbound and outbound calling features. Powered by automatic speech recognition, natural language processing and machine learning, Dialpad Vi provides Microsoft Teams users with real-time transcriptions, robust analytics, in-call coaching and intelligent conversation insights during every call.
“Today's technology and communications investments need to be in solutions that wholly integrate into how businesses work today, yet are flexible and scalable to evolve with them tomorrow,” said Craig Walker, Chief Executive Officer, Dialpad. “Today, more than 145 million people are using Microsoft Teams as their team collaboration tool, and nobody in the unified communications space does telephony services better than Dialpad. We’re excited to see the positive impact Dialpad direct routing will have on the calling experience for businesses using Microsoft Teams. With an open integration platform that natively extends and unifies business applications, Dialpad is delivering the best tools for teams to do their best work, both today and tomorrow.“
The coronavirus pandemic opened the business world’s eyes to new ways of working and ushered in the era of a hybrid work environment. Companies have implemented multiple tools to keep remote employees connected and engaged through video conferencing, messaging and chat tools, along with more traditional voice solutions. In addition to standard role responsibilities, employees face a new learning curve to integrate these tools into their workday. The management of multiple applications for a single, simple conversation can have detrimental effects on team productivity. Dialpad for Microsoft Teams centralizes and streamlines employee communications for more efficient, engaged, and ultimately, inclusive teams.
“The Dialpad integration with Microsoft Teams brings the best from both worlds — Microsoft Teams' collaboration and Dialpad's voice and real-time artificial intelligence capabilities,” said Ignacio Miranda, IT Vendor Manager, Gategroup. “An easy implementation and trouble-free user experience allows end-users to stay connected from anywhere, on any device, and enjoy a much better experience.”
From small and midsize businesses to large enterprises, organizations need a secure and reliable communications solution that enables seamless internal and external connections. Built for today’s modern hybrid workforce, Dialpad for Microsoft Teams provides a dynamic, flexible, highly scalable and reliable solution that is available on any device, at any time, anywhere in the world.
“Dialpad has focused on supporting highly distributed organizations and improving operational efficiency and productivity through its mobile-first, cloud-based unified communications and contact center solutions since its early days,” said Raul Castanon-Martinez, Senior Analyst, 451 Research, part of S&P Global Market Intelligence. “The integration with Microsoft Teams shows that the company continues to build and expand on this vision.”
See the Dialpad App Marketplace for more information on Dialpad for Microsoft Teams.
Additional Resources
- Check the latest blog for more details of Dialpad for Microsoft Teams.
- Learn why Dialpad is a Major Player in the IDC MarketScape: Worldwide UCaaS Service Providers for SMB and Enterprise 2021 Vendor Assessments
- Discover how Dialpad utilizes AI to unify UCaaS and CCaaS
About Dialpad
Dialpad is the leading cloud communications platform for AI-powered calling, conferencing and contact centers. Dialpad's proprietary, real-time Artificial Intelligence engine, Voice Intelligence (Vi™), helps businesses make smarter decisions by giving real-time insights on every call. Built on the Google Cloud Platform for unmatched security and reliability, Dialpad is easy to deploy, integrate and scale. Today, more than 70,000 of the world’s most innovative businesses use Dialpad and its seamless integrations with Google Workspace, Hubspot, Microsoft Office 365, Salesforce, Zendesk and others to allow every user to be more productive. Customers include T-Mobile, Twitter, WeWork, Uber, Stripe, Netflix, Motorola Solutions, Splunk and Domo. Dialpad is backed by the world’s leading investors including Amasia, Andreessen Horowitz, Felicis Ventures, GV, ICONIQ Capital, OMERS Growth Equity, Salesforce Ventures, Scale Ventures, Section 32, SoftBank Corp., T-Mobile Ventures and Work-Bench. Headquartered in the United States, Dialpad has offices in Australia/New Zealand, Brazil, Canada, India, Japan and the UK. Visit www.dialpad.com for more information and to request a demo.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210616006034/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Europe’s Largest Celebration of Irish Culture Arrives in Belfast2.8.2026 10:01:00 CEST | Press release
Fleadh Cheoil na hÉireann arrives in Belfast today (2 August), bringing eight days of traditional music, culture and celebration to the city, with organisers expecting up to 800,000 visitors over the course of the festival. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260729147569/en/ Belfast Fleadh - Maddens Bar accordian, guitar and fiddle player (Chris Heaney) One of Europe’s largest cultural events, Fleadh Cheoil na hÉireann is taking place in Belfast for the first time, transforming the city into a vibrant stage for Irish music, dance, language and culture. More than 200 events and 180 traditional music competitions are taking place across venues, streets and neighbourhoods throughout the week-long celebration. The landmark festival showcases the very best of Irish culture, with a packed programme of All-Ireland competitions, concerts, community events and performances from both established and emerging artists. As Ir
2PointZero Group Signals Global Scale With Revenue Surge to AED 21.9 Billion and Net Profit of AED 7.7 Billion in H1 202631.7.2026 13:42:00 CEST | Press release
Group revenue growth supported by stable gross profit margin of 29%, and adjusted EBITDA of AED 5.0 billionGlobal expansion milestones include the completed sale of TAQA stake, and the acquisition of Traverse Midstream Partners in North America, Baobab Group in Africa, and 60.8% of ISEM in ItalyTIME ranks the Group 36th on the World’s Growth Leaders list for 2026, highlighting market stability, operational scale and disciplined approach to capital 2PointZero Group (ADX: 2POINTZERO), a leading Abu Dhabi-based investment holding firm, announced its financial results for the first half of 2026, reporting revenue of AED 21.9 billion and delivering a Group Net Profit of AED 7.7 billion. This robust performance is reflected in the Group’s adjusted EBITDA, which reached AED 5.0 billion after excluding fair value changes and one-offs. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260731538982/en/ Samia Bouazza, CEO of 2PointZero (P
Datroway® Approved in the EU as Only TROP2 Directed Medicine with Overall Survival Benefit for the First-Line Treatment of Patients with Metastatic TNBC Who Are Not Candidates for Immunotherapy31.7.2026 08:30:00 CEST | Press release
Approval based on TROPION-Breast02 phase 3 trial results where Daiichi Sankyo and AstraZeneca’s Datroway showed a statistically significant and clinically meaningful improvement for the dual primary endpoints of overall survival and progression-free survival Datroway now approved for two breast cancer indications in the EU Datroway® (datopotamab deruxtecan) has been approved in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The approval by the European Commission follows the positive opinionof the Committee for Medicinal Products for Human Use of the European Medicines Agency and is based on result
Polpharma Biologics Announces FDA and EMA Acceptance for Review of PB016 Vedolizumab Biosimilar Candidate31.7.2026 08:30:00 CEST | Press release
Polpharma Biologics International AG today announces that the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have accepted for review the Biologics License Application (BLA) and Marketing Authorisation Application (MAA), respectively, for PB016, a proposed vedolizumab biosimilar candidate to Takeda’s reference product Entyvio®* (vedolizumab) lyophilized vial for intravenous (IV) administration for the treatment of adults with moderately to severely active ulcerative colitis and Crohn's disease. The BLA and MAA acceptances represent significant milestones in Polpharma Biologics' development program and underscore the company's commitment to advancing high-quality biosimilars and expanding global access to affordable biologic medicines. "FDA and EMA acceptances for review of our IV vedolizumab biosimilar candidate mark a major achievement for Polpharma Biologics and validate our deep scientific expertise in biosimilar development and manufacturing," said
SES: Disclosure of Share Buyback Transactions31.7.2026 07:30:00 CEST | Press release
In the time period from June 2, 2026 until and including June 23, 2026, a number of 213,167 shares were bought back within the framework of the share buyback of SES to meet obligations under SES’s Equity Based Compensation Plan (EBCP). Shares were bought back as follows: Day of purchase Aggregated volume in shares Daily weighted average acquisition price of shares (EUR) Market June 2, 2026 27,097 8.8727 DXE June 2, 2026 72,903 8.8556 ENX June 5, 2026 16,624 8.3723 DXE June 5, 2026 31,510 8.4266 ENX June 15, 2026 26,451 7.8423 XPAR June 17, 2026 26,812 7.3910 XPAR June 23, 2026 11,770 7.2200 XPAR The transactions in a detailed form are published on SES’s website: https://www.ses.com/investors/shareholder-information/share-buy-backs. Follow us on: Twitter | Facebook | YouTube | LinkedIn | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, busin
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom